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We have studied four patients (three male, one female, age range 15-25 years) with epilepsy, bilateral occipital calcifications 
and latent coeliac disease (CD). The epilepsy started at mean age 7 years, in three cases there were partial seizures and in 
one case generalized seizure. Three cases had symptoms suggesting malabsorptive syndrome during infancy and one case 
was diagnosed CD before the onset of seizures. In all cases serologic markers of CD were found, especially antiendomisium 
antibody, and intestinal biopsy indicated several grades of atrophy. The electroencephalograph (EEG) findings pointed to focal 
abnormalities in three patients and generalized abnormalities in one patient. In all cases computer tomography (CT) showed 
bilateral, almost symmetrical occipital calcifications in the cortical subcortical layers. The enhanced CT were unremarkable 
and magnetic resonance images (MRI) were normal. After diagnosis of CD, all patients followed a gluten-free diet and in 
three patients a significant reduction in seizure frequency was observed. CD should be ruled out in all cases of epilepsy, 
cerebral calcifications of unexplained origin and malabsorption syndrome in infancy. 
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INTRODUCTION 
The association of occipital calcifications, epilepsy 
and coeliac disease (CD) was first reported by Samar- 
itano et al1 in 1988. Since then, various series of 
patients have been published in which the presence 
of cerebral calcifications, epilepsy and CD have sug- 
gested the existence of an association or a new syn- 
drome with a possible common genetic origin, with- 
out ruling out other aetiopathogenetic possibilities 
such as those related to folic-acid deficiency. 
It is important to know and describe this association 
or syndrome for diagnostic purposes and in order to 
begin early therapy, particularly in those patients with 
poorly controlled seizures who, even without clinical 
evidence of malabsorption, meet the histopathological 
and analytical criteria for CD. 
We include in our study four new cases of epilepsy, 
cerebral calcifications and CD and stress the value of 
gluten-free diet in the clinical course of the neurolog- 
ical symptoms. 
PATIENTS AND METHODS 
Patients with occipital cerebral calcifications were se- 
lected from the Neurology, Neuroradiology and Pae- 
diatric Departments and from the clinical records of 
our hospital. 
The inclusion criterion was the finding of occipital 
cerebral calcifications in computer tomography (CT) 
with no associated cause after clinical history, phys- 
ical examination and different diagnosis tests. 
The following procedure was followed with the pa- 
tients included in the study. 
1. History: intended to find neurological disease, di- 
gestive disease (family and personal history of possi- 
ble malabsorption syndrome). 
2. Physical examination: neurological examination 
and assessment of possible signs suggesting malnu- 
trition or malabsorption. 
3. Additional tests: complete blood count, coagula- 
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Table 1: Clinical features of the seizures. 
Patient Sex Age Age at onset of seizure Type of seizure Frequency of seizures 
1 F 18 10 Partial motor 34/day 
2 M 25 10 Partial visual 2-3/week 
3 M 17 2 
4 M 15 10 





tion study, complete biochemical testing including 
(Ca, PTH), protein profile, blood levels of folic acid, 
vitamin Bt2, liposoluble vitamins, antigliadin anti- 
bodies (IgG, IgA), anti-endomysium antibodies (IgG, 
IgA) antireticulin antibodies (IgA, IgG). 
An intestinal biopsy was obtained in patients with 
positive antibody titres to confirm the diagnosis of 
CD. 
In patients with confirmed CD diagnosis and 
clinical signs of epilepsy, additional tests for 
epilepsy were conducted: electroencephalograph 
(EEG) (awake and asleep), magnetic resonance imag- 
ing (MRI) of the brain and in some cases, SPECT. 
In those patients with confirmed diagnosis of CD 
and epilepsy, a gluten-free diet was instituted with as- 
sessment of response to some of the epileptic seizures. 
RESULTS 
Four patients with occipital cerebral calcifications, 
CD and epilepsy were selected. All the patients were 
from Canary Island, without date referring to emigra- 
tion to other Mediterranean countries, background of 
Italian ancestors or of blood relationships. The mean 
age was 18 years with a range of 15-25 years. There 
was a slight male prevalence of three to 1 female. 
The neurological examination was normal in all pa- 
tients. The neuropsychological examination in two of 
the patients showed a mild cognitive deficit. Table 1 
shows the clinical findings. 
One patient had a family background of seizures 
of an unknown aetiology in the mother and one pa- 
tient had a family background of seizures, including 
a brother with CD. The disease began with epilepsy 
in two patients (at the age of 10 years and 8 months 
respectively) and cerebral calcifications were seen at 
diagnosis. The others cases were already known to 
have malabsorption syndrome (at the age of 2 years 
and 5 months respectively, finally attributed to CD at 
the age of 5 years and 7 years respectively). These 
patients developed epilepsy at the age of 26 months 
without cerebral calcifications in the cranial CT, and 
10 years with cerebral calcifications, respectively. 
In three patients, the seizures were partial with or 
without associated visual or occipital symptoms. One 
patient showed generalized and tonic-clonic seizures. 
The frequency of seizures was high from the onset 
(mean 2-3/week). 
The EEG showed a slowing down of the basal 
activity and poor reactivity with frequent focal ac- 
tivity becoming generalized. The abnormal activity 
consisted of spikes and/or spikes and waves in one 
or both parieto-occipital regions, often enhanced by 
eye closure. During the course of the seizure the EEG 
showed the persistence of paroxysmal abnormalities 
in all but one case. 
In all cases the CT scan showed bilateral, almost 
symmetrical, occipital calcification in the cortical- 
subcortical layers. In one case there was parietal cal- 
cification. The enhanced CT were unremarkable. The 
calcifications were cortical-subcortical and linear. Ta- 
ble 2 shows the findings of the CT scan. The MRI 
study of the calcifications were normal or showed 
the absence of a signal in the area corresponding to 
calcification. In two patients SPECT was carried out 
and one case showed hypoperfusion in the occipital 
area. All patients showed positive titre of antiendomi- 
sium or antigliadin antibodies and the jejunal biopsy 
showed partial villous atrophy. The values of folic 
acid were normal in three patients and one patient 
showed low values. 
After diagnosis of CD, all patients were prescribed 
a gluten-free diet with follow-up every 4 months. 
Two patients showed a significant reduction in fre- 
quency of seizures, one patient was seizure free and 
the other patient had irregular control. Table 3 shows 
the follow-up after a gluten-free diet. 
DISCUSSION 
Epidemiological aspects 
Most of the recent reports on epilepsy, occipital cal- 
cifications and CD are from Italy’-“, the rest com- 
ing from France12 and, recently, Spain13-t7 and Ar- 
gentina”. There are few reports in the literature 
from Anglo-Saxon countries or other nationalities and 
those are restricted to a few cases19,20. 
Coeliac disease is very common in Italy and the 
Mediterranean countries21,22, which is possibly one 
of the reasons why the syndrome association is more 
common. In countries with a very low CD preva- 
lence, such as Japan, China and Africa, no patients 
have been reported to date. 
The CD prevalence in Europe ranges from l/300 
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Table 2: Cranial CT calcifications findings. 
Patient Localization 





2 Bilateral occipital parietal Cortico-subcortical Nodular 
3 Bilateral occipital Cortical Linear 
4 Bilateral occipital Subcortical Nodular 
Table 3: Follow-up after gluten-free diet. 
Patient Follow-up (years) Seizure frequency Coeliac control Changed calcification 
1 3 Decreased 30% Good No 
2 2 Seizure free Good No 
3 4 Decreased 107~ Irregular No 
4 2 Decreased 50% Good No 
to l/2000 inhabitants23%25. Eating habits may possi- 
bly play some part in the prevalence of CD therefore 
in those countries with a large consumption of gluten- 
rich food, both the latent and clinical prevalence of 
the disease is higher21,22. 
There is no clear prevalence of either sex with re- 
gard to frequency, but in the larger series documented 
to date, there is a slight increase in women, particu- 
larly in those previously known to have suffered from 
CD”sl’. In our cases, there is a slight male preva- 
lence of 3 male to 1 female. 
The average age ranges from 14 to 16 years”,“. 
The mean age in our series was 18 years with a range 
of 15-25 years. The mean age is probably greater 
because most of the cases are from an adult neu- 
rology department unlike other studies which were 
conducted in neuropaediatric departments. 
EPILEPSY 
The epileptic seizures usually begin in early child- 
hood although they have been reported from the first 
year after birth”. In our series, the earliest case began 
at the age of 2 years. 
The epilepsy is usually partial, with or without as- 
sociated visual or occipital symptoms. Generalized 
tonic-clonic seizures have also been reported without 
a clear focal onset. No correlation has been found be- 
tween the extension of calcifications and the severity 
of epilepsy. Epilepsy can occur in as many as 5% of 
patients with CD26-2* and in these cases it was not 
associated with cerebral calcification. 
The existence of a greater focality is not always 
in proportion to more widespread calcification. Cal- 
cification is possibly not always related to the de- 
velopment of epileptic seizures in these patients and 
there may be independent foci of occipital calcifica- 
tion. Hence, the evolution time should be suitably 
assessed, particularly in those cases showing difficult 
therapeutic control in which new foci of activity may 
appear. 
In most patients with CD and calcifications, 
epilepsy is hard to control, multiple therapies 
are applied in many cases and drug-resistance is 
seen’%7, lo. “. 13. In patients with no previous diag- 
nosis of CD and in whom a gluten-free diet was 
prescribed, a better control of up to 50% was seen 
and some of them had no seizures for more than 
6 months”, I’, 28. In all our cases, better control of 
seizures was achieved and in case 2 they remitted for 
more than 6 months. The changes in the control of 
seizures do not appear to be related to the age of on- 
set of epilepsy, although they do appear to be related 
to the duration of epilepsy and diet compliance10, “. 
It has not been established how the institution of 
a gluten-free diet helps to control the seizures, al- 
though there may be pharmacokinetic factors, par- 
ticularly those related to a better absorption of the 
antiepileptic drug, owing to normalization of the in- 
testinal epithelium. In our cases, the application of 
the gluten-free diet has helped to improve the plasma 
levels of the drug. 
Other factors may help to relieve epileptic seizures 
in these patients, such as correction of anaemia and 
sideraemia, normalization of folic-acid levels and per- 
haps other possible metabolic disorders which could 
influence the control of seizures. 
CALCIFICATIONS 
The calcifications are located at the occipital level, 
often bilateral. Other sites, in order of frequency 
are: temporal, parietal and frontal, sometimes but not 
always with bioccipital calcifications. In the cases 
published no changes were seen in the evolutionary 
course and no changes are usually seen with the ad- 
ministration of contrasts. It is not clear at what mo- 
ment in the evolution of the disease the calcifica- 
tions first appear, since in most of the cases pub- 
lished they were seen at the time of diagnosis. In our 
series, case 3 showed no calcifications at onset of the 
epileptic seizures and it was only years later, when a 
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further control CT was made, that the calcifications 
were seen. The seizures had been badly controlled in 
this patient and low folic-acid levels were seen during 
their evolution. 
Calcifications are usually cortical-subcortical and 
linear, and occasionally nodular or serpiginous, sim- 
ilar to those appearing in Sturge-Weber’s syndrome, 
although the calcifications in that syndrome usually 
change after contrast administration, are associated 
with microgyria, lobar or hemispheric atrophy and are 
usually unilatera129, 30. In Sturge-Weber’s syndrome 
the existence of hypertrophic choroid plexuses and 
abnormalities in the cerebral venous drainage31 are 
usually common. No case of Sturge-Weber’s syn- 
drome has been reported with facial naevus and CD. 
The MRI study of the calcifications is usually nor- 
mal or showing the absence of a signal in the area cor- 
responding to calcification”. The brain SPECT stud- 
ies show a decrease in brain flow (hypoperfusion) in 
calcification sites9, as occurred in one of our cases. 
It is not easy to explain the preference of the calci- 
fications for the occipital level, but it could be due to 
the selective vulnerability of the occipital lobe32% 33. It 
has not been established that a gluten-free diet is able 
to change cerebral calcifications. The early institution 
of this diet and a suitable degree of compliance could 
help to prevent the development of calcification and 
even of epilepsy itself in these patients. 
OTHER NEUROLOGICAL SYMPTOMS 
Mild cognitive disorders may often occur in patients 
with epilepsy calcifications and CD, ranging from re- 
tarded psychomotor development to pictures of clear 
neuropsychological impairment. The inadequate con- 
trol of epilepsy can enhance neuropsychological im- 
pairments-“. 
Early diagnosis and treatment of CD could help 
to prevent neuropsychological impairment. Some au- 
thors’, ‘t have related the good control of the crises 
and the absence of impairment to a short CD duration. 
CD has been reported to be associated with demen- 
tia and cerebral atrophy, particularly in adults34. The 
aetiopathogenetic mechanisms in these cases are un- 
certain, although immunologically based mechanisms 
have been involved as well as those related to folic- 
acid metabolism. 
COELIAC DISEASE 
Since the first descriptions of patients with epilepsy, 
calcifications and CD it has not been established 
whether the occurrence of these symptoms and signs 
signifies an association, or rather, a syndrome. We are 
inclined to think that it is a syndrome in which the 
existence of several factors are possibly required to 
trigger completely the symptomatic triad. 
The origin of this syndrome is not clear and can 
hardly be explained by the existence of CD alone, 
therefore a common aetiopathogenetic factor should 
be considered, possibly mediated by some genetic 
component that might be influenced by a certain situ- 
ation conditioned by diet or secondary to a metabolic 
disorder in which folic acid changes could play a 
significant part. Most of the cases initially described 
have shown epileptic seizures and cerebral calcifica- 
tions (mainly occipital), the signs of CD having little 
clinical significance. 
The high prevalence of CD in patients with cere- 
bral calcifications and epilepsy may be similar to that 
found between dermatitis herpetiformis and CD. All, 
or almost all, patients with dermatitis herpetiformis 
have clinical or subclinical CD, whilst only a limited 
number of patients with CD have dermatitis herpeti- 
formis35, 36. 
Familiar cases have been reported of bioccipital cal- 
cifications and epilepsy not associated with CD, but 
with the same immunogenetic HLA markers as the 
latter37. Patients with epilepsy, calcifications and CD 
often have first-degree relatives with CD but without 
epilepsy or occipital calcifications as in our cases. 
Some patients, as in case 3 of our series, showed 
no occipital calcification at the onset of the clinical 
signs of epilepsy, but calcifications occurred associ- 
ated with frequent seizures. Patient compliance with 
the gluten-free diet in this case was fairly irregular 
and low folic-acid levels were seen on several oc- 
casions. These factors could possibly have enhanced 
the development of calcification and the poor control 
of the epileptic seizures. 
The anti-endomysium antibodies are those showing 
greater specificity and sensitivity, particularly when 
screening for the disease is being conducted in large 
populations . 22 On following up patients with CD, it 
has apparently not been possible to identify any de- 
termining factor of the development of cerebral cal- 
cification and epilepsy in such patients18,26. 
Different neurological disorders have been reported 
as related to CD, such as encephalopathy, cerebellar 
ataxia, dementia, myelopathy and peripheral neuropa- 
thy3841. Some of these disorders could be explained 
by a folic-acid deficiency, although in many of the 
cases described the folic acid was not measured. 
EPILEPSY, CALCIFICATIONS, CD AND FOLIC 
ACID 
Neurological disorders and cerebral calcifications 
have been found in iatrogenic folic-acid deficiency 
Epilepsy, cerebral calcifications and clinical or subclinical coeliac disease 53 
(treatment with methotrexate and radiotherapy)42a6 
and in congenital malabsorption of folic acid47,48. 
Calcification in cases of epilepsy, calcifications and 
CD can be caused by a folic-acid deficiency. In our 
series cases 3 and 4 showed folic-acid deficiency in 
some controls of their clinical follow-up, coinciding 
with a deterioration of the clinical course. No folic 
acid deficiency was reported in the Sturge-Weber 
syndrome with facial naevus49.50. 
Certain antiepileptic drugs such as phenytoin could 
exacerbate the folic-acid deficiency, impairing the 
clinical condition of epilepsy and possibly enhanc- 
ing the development of cerebral calcification in these 
patients5’. It is also possible that even though the 
serum and erythrocyte levels are normal, the folic 
acid could be abnormally absorbed and functionally 
deficient, as sometimes occurs with impaired vitamin 
B 12 metabolisms2. 
There are reports of the association of CD with dis- 
eases of autoimmune origin53-56, in some of which it 
has been possible to recognize a folic-acid deficiency, 
which could enhance the onset of the clinical triad. 
The folic-acid deficiency, combined with the ge- 
netic disorder of CD, may be the cause of the primary 
calcification process of the vessel wall and the cere- 
bral parenchyma at the level of the occipital cortex 
and the parallel or sequential development of epilep- 
tic seizures. 
In the treatment of the disease, folic acid must 
be administered in cases of deficiency and in those 
cases that are in the lower normal limits, and also 
the possibility of parental (intramuscular) administra- 
tion should be considered until the CD parameters are 
normal. 
In countries where the consumption of gliadin-rich 
foods is common, the possibility of the presence of 
CD should be considered in patients with epilepsy 
(particularly when resistant to therapy and of un- 
known origin) or with cerebral calcifications. 
Further studies are needed to establish the ae- 
tiopathogenetic bases of this complex and interesting 
syndromic association. 
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